医学界肿瘤频道|O药维持治疗1年以上显著延长晚期肺癌患者PFS;阿霉素联合K药治疗晚期肉瘤安全有效 | 肿瘤情报( 三 )


2. Waterhouse DM, Garon EB, Chandler J, McCleod M, Hussein M, Jotte R, Horn L, et al. Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153. Journal of Clinical Oncology 0: JCO.20.00131.
3. Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, et al. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial. Journal of Clinical Oncology 2020, JCO.20.01363.
4. Stijn van Roessel et al. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. JAMA Oncol. doi:10.1001/jamaoncol.2020.3537
5. Pollack SM, Redman MW, Baker KK, et al. Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial. JAMA Oncol. Published online September 10, 2020. doi:10.1001/jamaoncol.2020.3689
本文首发:医学界肿瘤频道
本文作者:肿瘤情报组
- End -
医学界肿瘤频道|O药维持治疗1年以上显著延长晚期肺癌患者PFS;阿霉素联合K药治疗晚期肉瘤安全有效 | 肿瘤情报
本文插图


推荐阅读